Company logo

ATHA - Athira Pharma, Inc.

NASDAQ -> Healthcare -> Biotechnology
Bothell, United States
Type: Equity

ATHA price evolution
ATHA
(in millions $) 31 Dec 2023 30 Oct 2023 30 Jun 2023 1 May 2023
Current assets
Cash $91.22 $110.97 $114.26 $105.81
Short term investments $56.84 $62.61 $72.46 $80.8
Net receivables
Inventory
Total current assets $154.73 $178.5 $192.13 $192.9
Long term investments $10.22 $33.9
Property, plant & equipment $4.44 $4.74 $5.01 $5.27
Goodwill & intangible assets
Total noncurrent assets $5.52 $6.2 $15.91 $39.88
Total investments $56.84 $62.61 $82.68 $114.7
Total assets $160.25 $184.7 $208.05 $232.77
Current liabilities
Accounts payable $0.13 $1.71 $0.61 $0.89
Deferred revenue
Short long term debt $0.37 $0.36 $0.35 $0.34
Total current liabilities $28.84 $28.62 $21.66 $20.15
Long term debt $1.22 $1.31 $1.41 $1.5
Total noncurrent liabilities $1.22 $1.31 $1.41 $1.5
Total debt $1.58 $1.67 $1.75 $1.83
Total liabilities $30.06 $29.94 $23.07 $21.65
Shareholders' equity
Retained earnings -$309.21 -$281.92 -$248.95 -$219.35
Other shareholder equity -$0.35 -$0.68 -$0.94 -$1.03
Total shareholder equity $130.19 $154.76 $184.98 $211.13
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $91.22 $96.39 $110.54 $60.63
Short term investments $56.84 $104.38 $143.22 $124.06
Net receivables $1.23 $2.34 $1.3
Inventory
Total current assets $154.73 $207.53 $260.8 $192.34
Long term investments $44.83 $65.94 $83.51
Property, plant & equipment $4.44 $5.32 $5.22 $3.58
Goodwill & intangible assets
Total noncurrent assets $5.52 $50.62 $71.21 $87.23
Total investments $56.84 $149.21 $209.16 $207.57
Total assets $160.25 $258.15 $332.01 $279.56
Current liabilities
Accounts payable $0.13 $2.5 $0.57 $1.16
Deferred revenue
Short long term debt $0.37 $0.33 $0.29 $0.12
Total current liabilities $28.84 $21.43 $9.29 $4.41
Long term debt $1.22 $1.58 $1.63 $0.88
Total noncurrent liabilities $1.22 $1.58 $1.63 $0.88
Total debt $1.58 $1.91 $1.92 $1
Total liabilities $30.06 $23.02 $10.92 $5.28
Shareholders' equity
Retained earnings -$309.21 -$191.53 -$95.89 -$41.04
Other shareholder equity -$0.35 -$1.96 -$0.39 $0.03
Total shareholder equity $130.19 $235.14 $321.08 $274.28
(in millions $) 31 Dec 2023 30 Oct 2023 30 Jun 2023 1 May 2023
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $23.68 $21.61
Selling, general & administrative $6.96 $10.03
Total operating expenses $29.01 $31.64
Operating income -$29.01 -$31.64
Income from continuing operations
EBIT -$27.29 -$29.6
Income tax expense
Interest expense
Net income
Net income -$27.29 -$29.6
Income (for common shares) -$27.29 -$29.6
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $93.79 $61.46 $42.79 $13.29
Selling, general & administrative $33.3 $32.55 $21.23 $6.71
Total operating expenses $125.47 $104.02 $64.02 $20
Operating income -$125.47 -$104.02 -$64.02 -$20
Income from continuing operations
EBIT -$117.67 -$95.64 -$54.85 -$19.95
Income tax expense
Interest expense
Net income
Net income -$117.67 -$95.64 -$54.85 -$19.95
Income (for common shares) -$117.67 -$95.64 -$54.85 -$19.95
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$27.29 -$32.97 -$29.6 -$27.82
Operating activities
Depreciation $0.3 $0.3 $0.3 $0.29
Business acquisitions & disposals
Stock-based compensation $2.23 $2.49 $3.12 $2.78
Total cash flows from operations -$26.29 -$23.98 -$24.28 -$26.19
Investing activities
Capital expenditures -$0.03 -$0.03 -$0.24
Investments $6.39 $20.72 $32.52 $35.76
Total cash flows from investing $6.39 $20.69 $32.49 $35.52
Financing activities
Dividends paid
Sale and purchase of stock $0.15 $0.24 $0.1
Net borrowings
Total cash flows from financing $0.15 $0.24 $0.1
Effect of exchange rate
Change in cash and equivalents -$19.75 -$3.29 $8.45 $9.43
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$117.67 -$95.64 -$54.85 -$19.95
Operating activities
Depreciation $1.18 $1.05 $0.48
Business acquisitions & disposals $0.04
Stock-based compensation $10.62 $10.61 $4.62 $0.63
Total cash flows from operations -$100.75 -$72.47 -$43.1 -$24.11
Investing activities
Capital expenditures -$0.3 -$1.14 -$1.57 -$2.32
Investments $95.39 $58.8 -$2.51 -$207.78
Total cash flows from investing $95.09 $57.66 -$4.08 -$210.07
Financing activities
Dividends paid
Sale and purchase of stock $0.49 $0.65 $97.09 $209.16
Net borrowings $1.66
Total cash flows from financing $0.49 $0.65 $97.09 $292.75
Effect of exchange rate
Change in cash and equivalents -$5.17 -$14.15 $49.91 $58.57
Fundamentals
Market cap $97.42M
Enterprise value $7.79M
Shares outstanding 38.05M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.75
Book/Share 3.43
Cash/Share 2.40
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.23
Net debt/EBITDA N/A
Current ratio 5.37
Quick ratio 5.37